Edesa Biotech, Inc. · NASDAQ:EDSA
Stempoint Capital LP reported a 9.90% stake in Edesa Biotech, Inc. (Schedule 13G)
Event Sep 30, 2026 · Filed Nov 16, 2026
Stempoint Capital LP reported a 9.90% stake in Edesa Biotech, Inc., 1,407,181 shares, as a passive investor on Sep 30, 2026. Filed Nov 16, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 1,407,181
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| StemPoint Capital LP | 9.90% | 1,407,181 |
| StemPoint Capital Management GP LLC | 9.90% | 1,407,181 |
| Michelle Ross | 9.90% | 1,407,181 |
Source
Download original · View original at SEC
Related
- Edesa Biotech, Inc.
- Stempoint Capital LP
- Edesa Biotech, Inc. shareholders
- Schedule 13G/A · Rubric Capital Management LP · Nov 16, 2026
- Schedule 13G · Boxer Capital Management, LLC · Nov 16, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Nov 16, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Nov 16, 2026
- Schedule 13G · Adage Capital Management, L.P. · Nov 12, 2026